policy
National Animal Health Laboratory Network (NAHLN) funding
The AVMA advocates for funding to develop and maintain infrastructure for a comprehensive National Animal Health Laboratory Network so that the U.S.…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Veterinary diagnostic laboratory funding
The AVMA encourages ongoing funding and support to develop and maintain monitoring, surveillance, and surge capacity within the Integrated Consortium…
JAVMA news
Finding viruses, identifying risks
Dennis Carroll, PhD, said identifying and cataloging the estimated half-million viruses with zoonotic potential would cost less than the expenditure…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
AVMA news
Veterinary college programs to address cross-species health risks
The veterinary schools at the University of Pennsylvania and Cornell University recently added programs designed to improve collaboration in work to…
AVMA news
In Short - Feb. 15, 2022
Highly pathogenic avian influenza has been found in Canada and the U.S., a resource offers advice on global veterinary careers, a meeting report from…
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…